Retatrutide is an investigational peptide that activates the GLP-1, GIP, and glucagon receptors. Its triple-receptor mechanism is being studied for its effects on appetite regulation, glucose control, energy expenditure, and body-weight reduction. This NextChems product is pharmacist-formulated, independently third-party tested, and supplied with a COA. Retatrutide has not yet received regulatory approval.
Keep reading
More articles
Brand Reviews
Yes Clinic Review: TRT, Weight Loss, and Sexual Wellness Care Online
Read
5 min read
The Morning Dose
The Morning Dose #20: Low T and Arthritis, ZepBound, and a New Anti-Aging Molecule
Read
7 min read
The Morning Dose
The Morning Dose #21: Superfoods and Depression, Cognitive Benefits of Exercise, and Black Friday Savings!
Read
6 min read
The Morning Dose · Free weekly
The research that matters, in five minutes a week.
Join 15,000+ readers getting the sharpest peptide, TRT, and SARMs research and news broken down without the hype. One email. No filler.
Latest issue
#23
The Morning Dose #23: Cholesterol, Probiotics, and Low-Carb vs. Low-Fat Diets
Read time · 6 min
Read this issue →